The
UCSF Thoracic Oncology
Laboratory led by David Jablons, M.D., Professor
and Chief of Thoracic Surgery and Program Leader of Thoracic
Oncology, recently launched its first Lung Cancer Joint
Laboratory in China, an alliance with Guangzhou Institute
of Respiratory Disease (China National Key Laboratory of
Respiratory Disease) and the First Affiliated Hospital of Guangzhou
Medical College. A signing ceremony was held in
Guangzhou, China on March 31, 2010
that included David Jablons, M.D., Professor
and Chief of Thoracic Surgery at UCSF and
Program Leader of the Thoracic Oncology
Program, UCSF Department of Surgery, Michael Mann, M.D. and Zhidong Xu, Ph.D., (pictured
left) Nanshan Zhong, M.D., Ph.D., Professor and Director of
Guangzhou Institute of Respiratory Disease, Jianxing He, M.D.,
Ph.D., Professor and President of the First Affiliated Hospital of
Guangzhou Medical College as well
as numerous physicians, researchers, and
students.
The joint lab will advance lung cancer research and develop molecular-based technologies for diagnosis and personalized treatment. "This opens up a great opportunity the U.S. and China to jointly study lung cancer, the deadliest of diseases", said Dr. Jablons. "It is a historic moment as we three research institutes join together and conduct international collaboration for the study of lung cancer", said Professor Zhong.
